Barclays’s NanoViricides NNVC Stock Holding History

Barclays’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Hold	0	–	–	–	7174
2018 Q1	–	Hold	0	–	–	–	7241
2015 Q2	–	Sell	-65	Closed	-$2K	–	7139
2015 Q1	$2K	Sell	65 -57	-47%	-$3.04K	﹤0.01%	6872
2014 Q4	$5K	Buy	122 +33	+37%	+$2.18K	﹤0.01%	6976
2014 Q3	$5K	Buy	89 +41	+85%	+$3.22K	﹤0.01%	7190
2014 Q2	$4K	Buy	+48	New	+$3.41K	﹤0.01%	7198

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PTB

Pioneer Trust Bank Salem, Oregon $441M AUM 21.13% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

SCA

STALEY CAPITAL ADVISERS Pittsburgh, Pennsylvania $2.57B AUM 26.96% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Barclays's NNVC Position: Q2 2018 in Review

Barclays held its NanoViricides (NNVC) position steady in Q2 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7174.

Barclays first reported a position in NNVC in Q2 2014 and has held it in 4 quarters since. The position peaked at $5K in Q4 2014. 42 funds tracked by Wall St. Rank hold NNVC as of Q2 2018.

Barclays held 0 shares of NanoViricides worth $0 as of Q2 2018.
Barclays left its NanoViricides share count unchanged in Q2 2018.
NanoViricides made up ﹤0.01% of Barclays's portfolio in Q2 2018, its #7174 holding.
Barclays first reported a position in NanoViricides in Q2 2014 and has held it in 4 quarters since.
Barclays's NanoViricides position peaked at $5K in Q4 2014.
42 funds tracked by Wall St. Rank held NanoViricides as of Q2 2018.

Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.